Khandakar A. S. M. Saadat

Khandakar A. S. M. Saadat

Auto-generated profile, based on publicly available information

Khandakar A. S. M. Saadat

Department of Medical Biology and Genetics, School of Medicine, Graduate School of Health Sciences, Gaziantep University, Gaziantep, 27310, Republic of Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in FEBS Open Bio
Verified
Journal Article
Open access
KSKhandakar A.S.M. Saadat
Khandakar A.S.M. Saadat
YMYusuke Murakami
Yusuke Murakami
XTXue Tan
Xue Tan
YNYoko Nomura
Yoko Nomura
TYTsutomu Yasukawa
Tsutomu Yasukawa
YYYasuo Yanagi
Yasuo Yanagi
In this study, we show augmented autophagy in the retinal pigment epithelial cell line ARPE‐19 when cultured in the presence of the lipofuscin pigment A2E. A2E alone does not induce RPE cell death, but cell death was induced in the presence of A2E with the autophagy inhibitor 3‐methyladenine (3MA), with a concomitant increase in the generation of mitochondrial reactive oxygen species. On the other hand, the ATP production capacity of mitochondria was decreased in the presence of A2E, and pharmacological inhibition of autophagy had no additional effects. The altered mRNA expression level of mitochondrial function markers was confirmed by real‐time polymerase chain reaction, which showed that the antioxidant enzymes SOD1 and SOD2 were not reduced in the presence of A2E alone, but significantly suppressed with the addition of 3MA. Furthermore, transmission electron micrography revealed autophagic vacuole formation in the presence of A2E, and inhibition of autophagy resulted in the accumulation of abnormal mitochondria with loss of cristae. Spheroid culture of human RPE cells demonstrated debris accumulation in the presence of A2E, and this accumulation was accelerated in the presence of 3MA. These results indicate that autophagy in RPE cells is a vital cytoprotective process that prevents the accumulation of damaged cellular molecules.


1 March 2019 in Gene
Verified
Journal Article
Closed access
Muhammetnur TekayevMuhammetnur Tekayev
Muhammetnur Tekayev
NBNuray Bostancieri
Nuray Bostancieri
KSKhandakar A.S.M. Saadat
Khandakar A.S.M. Saadat
MTMehmet Turker
Mehmet Turker
MYMehmet Yuncu
Mehmet Yuncu
KAKaifee Arman
Kaifee Arman

1 October 2015 in JRSM Open
Verified
Journal Article
Open access
MRMosiur Rahman
Mosiur Rahman
SHSyed Haque
Syed Haque
JIJahirul Islam
Jahirul Islam
GMGolam Mostofa
Golam Mostofa
KSKhandakar Asm Saadat
Khandakar Asm Saadat
Objectives: This study aimed to examine if socioeconomic status could affect the likelihood of diagnosis, treatment and control of hypertension in diabetic hypertensive individuals. Design: Cross-sectional nationally representative study. Settings: Bangladesh. Participants: This paper used data from the 2011 Bangladesh Demographic Health Survey. The analyses were based on the responses of 339 diabetes hypertensive individuals. Main outcome measures: Diagnosis, treatment and control of hypertension. Results: The age-adjusted prevalence of hypertension in diabetes individuals was 38.4% in the study population. Among diabetic hypertensive subjects only 65.7% had been diagnosed, 58.4% were receiving treatment and 42% controlled their hypertension. Individuals from high socioeconomic status (AOR 2.60; 95% CI 1.16–5.83) had an increased likelihood of reporting diagnosis of hypertension. Individuals from medium (AOR 2.22; 95% CI 1.11–4.46) and high socioeconomic status (AOR 3.47; 95% CI 1.59–7.58) had increased chance of receiving treatment. In addition, individuals belonging to high socioeconomic status (AOR 2.53; 95% CI 1.14–5.63) were more likely to report of controlling hypertension. Conclusions: This study indicated that hypertension is more prevalent among diabetic patients. Furthermore, diabetic hypertensive patients from the low socioeconomic status group are also less likely to be diagnosed and also less likely to receive treatment for hypertension. In addition, diabetic hypertensive patients from the low socioeconomic status were less likely to control hypertension compared with an individual belonging to the high socioeconomic status group. This reduced likelihood of receiving proper treatment will lead to a rapid increase in the prevalence of macrovascular and microvascular diseases among diabetic hypertensive patients.

1 December 2021 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
CPCuneyd Parlayan
Cuneyd Parlayan
YSYunus Sahin
Yunus Sahin
ZAZekiye Altan
Zekiye Altan
KAKaifee Arman
Kaifee Arman
MIMasa-Aki Ikeda
Masa-Aki Ikeda
KSKhandakar A.S.M. Saadat
Khandakar A.S.M. Saadat

13 February 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
DGDeniz Gazel
Deniz Gazel
MEMehmet Erinmez
Mehmet Erinmez
GCGonenc Caliskanturk
Gonenc Caliskanturk
KSKhandakar A. S. M. Saadat
Khandakar A. S. M. Saadat
Methylene blue (MB) is a water-soluble dye that has a number of medical applications. Methicillin-resistant Staphylococcus aureus (MRSA) was selected as a subject for research due to the numerous serious clinical diseases it might cause and because there is a significant global resistance challenge. Our main goal was to determine and analyze the antibacterial effects of MB against S. aureus both in vitro and ex vivo to enhance treatment options. A total of 104 MRSA isolates recovered from various clinical specimens were included in this study. Minimum inhibitory concentration (MIC) values of MB against MRSA isolates were determined by the agar dilution method. One randomly selected MRSA isolate and a methicillin-susceptible S. aureus strain (S. aureus ATCC 25923) were employed for further evaluation of the antibacterial effects of MB in in vitro and ex vivo time-kill assays. A disc diffusion method-based MB + antibiotic synergy assay was performed to analyze the subinhibitory effects of MB on ten isolates. MICs of MB against 104 MRSA isolates, detected by the agar dilution method, ranged between 16 and 64 µg/mL. MB concentrations of 4 and 16 µg/mL showed a bactericidal effect at 24 h in the ex vivo time-kill assays and in vitro time-kill assays, respectively. We observed a significant synergy between cefoxitin and methylene blue at a concentration of 1–2 μg/mL in two (20%) test isolates. Employing MB, which has well-defined pharmacokinetics, bioavailability, and safety profiles, for the treatment of MRSA infections and nasal decolonization could be a good strategy.